The Law Offices of Frank R. Cruz announces an investigation on behalf of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI) investors concerning the Company and its officers’ possible violations of federal securities laws.
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors
Zacks.com featured highlights include: eXp, American States Water, ICU Medical, Universal Technical Institute and SFL
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of ICU Medical, Inc. (NASDAQ: ICUI) resulting from allegations that ICU Medical may have issued materially misleading business information to the investing public.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors
Zacks.com featured highlights include: Gibraltar Industries, PJT Partners, ICU Medical, eXp World and Innovative Industrial Properties
NEW YORK, NY / ACCESSWIRE / May 14, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU" or "the Company") ...
Q1 2020 ICU Medical Inc Earnings Call
SAN CLEMENTE, Calif., May 07, 2020 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy.
ICU Medical, Inc. is voluntarily recalling one single lot of Lactated Ringer's Injection, USP. The products are being recalled to the hospital/user level due to the presence of particulate matter identified as iron oxide. ICU Medical became aware of this issue through a single customer complaint.
SAN CLEMENTE, Calif., April 20, 2020 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
Today we are going to look at ICU Medical, Inc. (NASDAQ:ICUI) to see whether it might be an attractive investment...
LOS ANGELES, May 20, 2020 -- The Portnoy Law Firm advises ICU Medical, Inc. (NASDAQ: ICUI) investors that the firm has initiated an investigation into possible securities.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU Medical” or the “Company”) (ICUI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether ICU Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thank you for joining us today to discuss the ICU Medical financial results for the first quarter of 2020. On the call today representing ICU Medical is Vivek Jain, Chief Executive Officer and Chairman; and Brian Bonnell, Chief Financial Officer.
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ICU Medical, Inc.